188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours

Autor: Imbimbo, M., Hollebecque, A., Italiano, A., McKean, M., Macarulla, T., Castanon Alvarez, E., Carneiro, B.A., Mager, R., Barnhart, V., Murtomaki, E., He, Y., Cooper, Z.A., Tu, E., Linke, A., Fan, C., Zhou, D., Boyer Chammard, A., Paturel, C.L., Fraenkel, P.G., Powderly, J.
Zdroj: In Immuno-Oncology and Technology December 2022 16 Supplement 1
Databáze: ScienceDirect